Thus, to assess whether KLF7 can trigger pathological cardiac hypertrophy by balancing the expression of PFKL and ACADL in vivo, we generated transgenic mice (TG) in a cardiac myocyte-specific manner (Fig. 5a). This evidence concerns the gene ACADL and cardiac hypertrophy.